Clinical Evaluation of a Bulk Fill Resin Composite

Sponsor
Ivoclar Vivadent AG (Industry)
Overall Status
Active, not recruiting
CT.gov ID
NCT04686422
Collaborator
(none)
39
1
1
54.9
0.7

Study Details

Study Description

Brief Summary

The purpose of this clinical trial is to measure the clinical outcomes of Tetric PowerFill Class I and II restorations cured in 3 seconds with the Bluephase PowerCure curing unit.

Condition or Disease Intervention/Treatment Phase
  • Device: Tetric PowerFill
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
39 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Clinical Evaluation of a Bulk Fill Resin Composite
Actual Study Start Date :
Dec 1, 2017
Anticipated Primary Completion Date :
Jun 30, 2022
Anticipated Study Completion Date :
Jun 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Tetric PowerFill Class I and II restorations

Device: Tetric PowerFill
Tooth (teeth) affected by dental caries or with an existing defective filling will be restored using the PowerCure system.

Outcome Measures

Primary Outcome Measures

  1. postoperative hypersensitivity [Baseline to 36 months]

    assessed by tests with thermal stimuli and occlusal forces (during biting) determined by VAS (Visual Analog Scale, 0 "No pain at all" - 10 "The worst pain imaginable") following the FDI criteria on a scale from 1 "very good" to 5 "unacceptable"

  2. Pulp integrity [Baseline to 36 months]

    Restored teeth are assessed by a cold air stimuli test (air syringe) by VAS (Visual Analog Scale, 0 "No pain at all" - 10 "The worst pain imaginable")

  3. Overall survival rate [36 months]

    Kaplan-Meier survival analysis will be performed to estimate the lifetime of the material based on clinical failures

Secondary Outcome Measures

  1. FDI criteria (Surface lustre, surface staining, colour match, material fracture, occlusal wear, tooth integrity) [Baseline to 36 months]

    assessed following the FDI criteria on a scale from 1 "very good" to 5 "unacceptable"

Eligibility Criteria

Criteria

Ages Eligible for Study:
19 Years to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Each subject must need at least 1 restoration in a vital posterior tooth

  • Must have given written consent to participate in the trial

  • Replacement of defective restorations (i.e. fractured, stained, unaesthetic) with or with-out caries are acceptable

  • Must be available for the required follow-up visits over 3 years

  • Restored teeth must have occlusal contact with opposing teeth or restored teeth

  • Restoration width should be equal to or greater than 1/3 the distance from buccal to lin-gual cusp tips

  • 75% of the restorations Class II (minimum) and 25% Class I

  • Each Class II will have at least one proximal contact

  • 75% in molars (minimum) and 25% in premolars

  • All restored teeth must have at least one occlusal contact in habitual closure

  • Must have 20 or more teeth

Exclusion Criteria:
  • If they have an allergy to ingredients of the materials under investigation (monomers)

  • Do not meet all inclusion criteria above

  • Have severe medical complications (organ transplants, long term antibiotic or steroid treatment, cancer or are immunocompromised) or disabilities meaning they may not be able to tolerate the time required to complete the restorations or to provide adequate oral hygiene

  • Have xerostomia either by taking medications known to produce xerostomia or those with radiation-induced xerostomia or Sjogren's syndrome - as dry mouth increases tooth and restoration wear as well as the development of caries.

  • Have teeth with advanced or severe periodontitis, rampant caries or poor oral hygiene which may require extraction of the teeth to be restored

  • Present with any systemic or local disorders that contraindicate the dental procedures included in this study

  • Have unstable occlusion

  • Have severe grinding/bruxing or clenching or need TMJ-related therapy

  • Have tooth with exposed pulp during preparation or caries removal

  • Teeth that are non-vital or that exhibit signs of pulpal pathology for restoration

  • Teeth that require cuspal build-ups involving more than one cusp

Contacts and Locations

Locations

Site City State Country Postal Code
1 UAB School of Dentistry Birmingham Alabama United States 35294-0007

Sponsors and Collaborators

  • Ivoclar Vivadent AG

Investigators

  • Principal Investigator: Nathaniel Lawson, Dr, UAB School of Dentistry

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ivoclar Vivadent AG
ClinicalTrials.gov Identifier:
NCT04686422
Other Study ID Numbers:
  • LL3079573
First Posted:
Dec 28, 2020
Last Update Posted:
Apr 11, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 11, 2022